DOCSLIB.ORG

Susan Gottesman, Phd National Institutes of Health

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Susan Gottesman, Phd National Institutes of Health Boston Bacterial Meeting 2017 Crystal structure of Hfq in a complex with sRNA, Keynote speaker: RNA binding interfaces highlighted. Modeled using PDB: 4V2S Susan Gottesman, PhD National Institutes of Health Generously sponsored by: 2017 Boston Bacterial Meeting - Schedule and Introduction Thursday June 15 12:00 pm Registration 12:45 pm Opening Remarks I: Bacterial communities Chair: Matthew Ramsey Stephanie High-throughput analysis of targeted mutant libraries reveals new 1:00 pm Shames Legionella pneumophila effector virulence phenotypes Microbial hitchhiking promotes dispersal and colonization of new niches 1:20 pm Tahoura Samad by staphylococci Interactions between species introduce spurious associations in 1:40 pm Rajita Menon microbiome studies: evidence from inflammatory bowel disease The upper respiratory tract commensal Dolosigranulum pigrum inhibits 2:00 pm Silvio Brugger Staphylococcus aureus 2:20 pm Coffee Break II: Morphogenesis Chair: Eddie Geisinger Determining how bacteria regulate their rate of growth at the single- 2:50 pm Yingjie Sun molecule and single-cell levels by super-resolution microscopy Metabolic control of cell morphogenesis: perturbed TCA cycle halts 3:10 pm Irnov Irnov peptidoglycan biosynthesis Membrane remodeling at the division septum by the bacterial actin 3:30 pm Joseph Conti homolog FtsA 3:50 pm Kristin Little A cell envelope stress response system keeps cells in shape 4:10 pm Poster Session I - Science Center (#1-32, 60-66) III: Treatment strategies Chair: Alex Kostic Sebastien 5:30 pm BRACE for resistance: teaching phages to think ahead. Lemire 5:50 pm Jimmy Patel Novel Chemical Tools to Combat Drug-Resistant S. aureus Infection Systems Analysis Identifies Metabolic Components to Antibiotic 6:10 pm Jason Yang Susceptibility and Tolerance 6:30-8:30 PM Reception 1 2017 Boston Bacterial Meeting - Schedule and Introduction Friday June 16 8:30 am Morning Coffee IV: Gene expression Chair: Alexandra Deaconescu Kathleen A clock-phased sigma factor cascade times global circadian 9:00 am Fleming transcriptional rhythms in cyanobacteria Pervasive targeting of nascent transcripts by the RNA chaperone Hfq in 9:20 am Tracy Kambara Pseudomonas aeruginosa Transcriptome analysis of synchronously replicating Mycobacterium 9:40 am Aditya Bandekar tuberculosis yields novel insights into the interplay between cell cycle progression and physiology 10:00 am Poster Session II - Plaza Tent (#33-59, 67-123) V: Metabolism Chair: Robert Bruckner Nitrate respiration provides pH dependent fitness and persistence in 11:20 am Emilio Bueno Vibrio cholerae 11:40 am David Cameron Genetic analysis of persister formation in Pseudomonas aeruginosa The Interplay Between the Regulation of Serine Metabolism and Biofilm 12:00 am Jen Greenwich Formation in Bacillus subtilis 12:20 pm Lunch (Breakout Sessions begin at 12:45) VI: Ecology and evolution Chair: Katja Taute Changes in antibiotic use drive enterococcal evolution during an extended 2:00 pm Daria Van Tyne hospital outbreak 2:20 pm Nicole Vega Ecology of bacterial community assembly in a C. elegans host model Jean-Benoit 2:40 pm Convergent protein expression stoichiometry in divergent bacteria Lalanne Leonora Convergence in the microbiomes of natural plant-associated microcosms 3:00 pm Bittleston on different continents 3:20 pm Coffee Break VII: Stress responses Chair: Jeremy Rock Meghan BB0017 is required for virulence and resistance to oxidative stress in the 3:50 pm Ramsey Lyme disease bacterium Borrelia burgdorferi Factors that modulate RecA localization to replication forks with and 4:10 pm Caroline Qin without UV radiation. Diego Vargas Regulation of mRNA stability in mycobacteria as an adaptive response to 4:30 pm Blanco stress conditions 4:50 pm Coffee Break 5:10 pm Keynote Address: Susan Gottesman 6:20 - 8:00 PM Reception Please silence your mobile devices before entering the lecture hall and breakout sessions. Recording or photography of oral or poster presentations is prohibited. Please keep your name badge on at all times during the meeting. Room 111 is available as a mothers' room. A portion of the funding for this year’s conference was made possible by grant R13AI131601 from the National Institute of Allergy and Infectious Diseases. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government. 2 2017 Boston Bacterial Meeting - Schedule and Introduction WELCOME! Dear Participants, On behalf of the BBM2017 Organizing Committee, we thank you for attending the 23rd Boston Bacterial Meeting! Over the past 23 years, the BBM has offered an intellectually stimulating and collegial atmosphere for bacteriologists throughout the New England area to discuss cutting-edge scientific research and to share ideas. The BBM is also proud to provide a forum that fosters collaborations between researchers from all levels, within both academia and industry. The BBM has grown significantly since its inception. The past few years have seen record-breaking participation from researchers both near and far. Given last year’s success and by popular demand we have brought back the interactive break out sessions lead by leaders in several fields within microbiology. This year we are also excited about the launching of our new website www.bostonbacterial.org. Although the BBM has undergone many changes over the last 23 years, one crucial element has remained consistent: our commitment to the highest quality research. This is particularly evident in the 24 talks and over 120 posters that will be presented at this year’s meeting. This year we are excited to feature Dr. Susan Gottesman as our Keynote Speaker. Dr. Gottesman is an NIH Distinguished Investigator, Head of the Biochemical Genetics Section at the National Cancer Institute, which is part of the National Institutes of Health (NIH). Dr. Gottesman has pioneered studies on post-transcriptional mechanisms of regulation in bacterial systems, with a focus on the role of energy-dependent proteolysis in regulation and the role of small non-coding RNAs in regulating translation and mRNA stability. Dr. Gottesman is a member of the National Academy of Sciences and the American Academy of Arts and Sciences. She received the Abbott-ASM Lifetime Achievement Award in 2011. The BBM would not be possible without the efforts of the Organizing Committee, a highly motivated and enthusiastic group of graduate students and postdocs dedicated to the success of this meeting. We are also indebted to our faculty sponsors, Tom Bernhardt and Ethan Garner, and meeting founders, Rich Losick, Roberto Kolter, John Mekalanos, and Andrew Wright, and thank them for their continuing guidance. Additionally, we thank our generous industry and NIH sponsors for their financial support! Finally, we thank all of you for your participation and support of the BBM. We hope you will find the next two days both intellectually and socially fulfilling. Thank you for joining us! Patty Rohs and Florencia Caro Co-chairs, BBM2017 3 2017 Boston Bacterial Meeting - Schedule and Introduction KEYNOTE SPEAKER SUSAN GOTTESMAN, PH.D. Susan Gottesman is an NIH Distinguished Investigator in the Biochemical Genetics Section at the National Cancer Institute (NCI), which is part of the National Institutes of Health (NIH). Dr. Gottesman has pioneered studies on post- transcriptional mechanisms of regulation in bacterial systems, with a focus on the role of energy-dependent proteolysis in regulation and the role of small non-coding RNAs in regulating translation and mRNA stability. One focus of her work has been on how these regulatory inputs affect the bacteria’s response to stress. Her laboratory has been interested in novel mechanisms for gene regulation and how these mechanisms contribute to global control circuits in Escherichia coli (E. coli). For many years, the focus of the laboratory was energy-dependent proteolysis. In the past decade, much of the lab has shifted to studying small regulatory RNAs, although they continue to investigate the mechanisms for regulating energy-dependent proteolysis. Her group first encountered small RNAs when studying the regulation of synthesis of a substrate for energy-dependent proteases. They continue to see significant overlap between mRNAs regulated by small RNAs and the products of these mRNAs that are regulated by proteolysis. Dr. Gottesman received her Ph.D. from the Department of Microbiology at Harvard University and became a postdoctoral fellow at the NIH. She then went to the Massachusetts Institute of Technology (MIT) as a research associate and returned to the NIH in 1976 as a senior investigator in the Laboratory of Molecular Biology, where she has remained. She was elected to the National Academy of Sciences in 1998 and the American Academy of Arts and Sciences in 1999. She received the Abbott-ASM Lifetime Achievement Award in 2011. This profile information was adapted from the NIH https://ccr.cancer.gov/Laboratory-of-Molecular- Biology/susan-gottesman 4 2017 Boston Bacterial Meeting – New Faculty NEW MEMBERS OF THE ACADEMIC COMMUNITY As part of the BBM’s goal to foster interactions and collaborations between various individuals and their institutions, we would like to highlight the new members of our research community who have recently begun their appointments. We encourage everyone to provide
Load more

Recommended publications
  • Genomic Stability and Genetic Defense Systems in Dolosigranulum Pigrum A
    bioRxiv preprint doi: https://doi.org/10.1101/2021.04.16.440249; this version posted April 18, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. 1 Genomic Stability and Genetic Defense Systems in Dolosigranulum pigrum a 2 Candidate Beneficial Bacterium from the Human Microbiome 3 4 Stephany Flores Ramosa, Silvio D. Bruggera,b,c, Isabel Fernandez Escapaa,c,d, Chelsey A. 5 Skeetea, Sean L. Cottona, Sara M. Eslamia, Wei Gaoa,c, Lindsey Bomara,c, Tommy H. 6 Trand, Dakota S. Jonese, Samuel Minote, Richard J. Robertsf, Christopher D. 7 Johnstona,c,e#, Katherine P. Lemona,d,g,h# 8 9 aThe Forsyth Institute (Microbiology), Cambridge, MA, USA 10 bDepartment of Infectious Diseases and Hospital Epidemiology, University Hospital 11 Zurich, University of Zurich, Zurich, Switzerland 12 cDepartment of Oral Medicine, Infection and Immunity, Harvard School of Dental 13 Medicine, Boston, MA, USA 14 dAlkek Center for Metagenomics & Microbiome Research, Department of Molecular 15 Virology & Microbiology, Baylor College of Medicine, Houston, Texas, USA 16 eVaccine and Infectious Diseases Division, Fred Hutchinson Cancer Research Center, 17 Seattle, WA, USA 18 fNew England Biolabs, Ipswich, MA, USA 19 gDivision of Infectious Diseases, Boston Children’s Hospital, Harvard Medical School, 20 Boston, MA, USA 21 hSection of Infectious Diseases, Texas Children’s Hospital, Department of Pediatrics, 22 Baylor College of Medicine, Houston, Texas, USA 23 bioRxiv preprint doi: https://doi.org/10.1101/2021.04.16.440249; this version posted April 18, 2021.
    [Show full text]
  • Allofustis Seminis Gen. Nov., Sp. Nov., a Novel Gram-Positive, Catalase-Negative, Rod-Shaped Bacterium from Pig Semen
    International Journal of Systematic and Evolutionary Microbiology (2003), 53, 811–814 DOI 10.1099/ijs.0.02484-0 Allofustis seminis gen. nov., sp. nov., a novel Gram-positive, catalase-negative, rod-shaped bacterium from pig semen Matthew D. Collins,1 Robert Higgins,2 Serge Messier,2 Madeleine Fortin,2 Roger A. Hutson,1 Paul A. Lawson1 and Enevold Falsen3 Correspondence 1School of Food Biosciences, University of Reading, Whiteknights, Reading RG6 6AP, UK Matthew D. Collins 2Universite´ de Montre´al, Faculte´ de Me´decine Ve´te´rinaire, St Hyacinthe, Quebec, Canada [email protected] 3Culture Collection, Department of Clinical Bacteriology, University of Go¨teborg, Sweden An unknown Gram-positive, catalase-negative, facultatively anaerobic, non-spore-forming, rod-shaped bacterium originating from semen of a pig was characterized using phenotypic, molecular chemical and molecular phylogenetic methods. Chemical studies revealed the presence of a directly cross-linked cell wall murein based on L-lysine and a DNA G+C content of 39 mol%. Comparative 16S rRNA gene sequencing showed that the unidentified rod-shaped organism formed a hitherto unknown subline related, albeit loosely, to Alkalibacterium olivapovliticus, Alloiococcus otitis, Dolosigranulum pigrum and related organisms, in the low-G+C-content Gram-positive bacteria. However, sequence divergence values of >11 % from these recognized taxa clearly indicated that the novel bacterium represents a separate genus. Based on phenotypic and phylogenetic considerations, it is proposed that the unknown bacterium from pig semen be classified as a new genus and species, Allofustis seminis gen. nov., sp. nov. The type strain is strain 01-570-1T (=CCUG 45438T=CIP 107425T).
    [Show full text]
  • From Genotype to Phenotype: Inferring Relationships Between Microbial Traits and Genomic Components
    From genotype to phenotype: inferring relationships between microbial traits and genomic components Inaugural-Dissertation zur Erlangung des Doktorgrades der Mathematisch-Naturwissenschaftlichen Fakult¨at der Heinrich-Heine-Universit¨atD¨usseldorf vorgelegt von Aaron Weimann aus Oberhausen D¨usseldorf,29.08.16 aus dem Institut f¨urInformatik der Heinrich-Heine-Universit¨atD¨usseldorf Gedruckt mit der Genehmigung der Mathemathisch-Naturwissenschaftlichen Fakult¨atder Heinrich-Heine-Universit¨atD¨usseldorf Referent: Prof. Dr. Alice C. McHardy Koreferent: Prof. Dr. Martin J. Lercher Tag der m¨undlichen Pr¨ufung: 24.02.17 Selbststandigkeitserkl¨ arung¨ Hiermit erkl¨areich, dass ich die vorliegende Dissertation eigenst¨andigund ohne fremde Hilfe angefertig habe. Arbeiten Dritter wurden entsprechend zitiert. Diese Dissertation wurde bisher in dieser oder ¨ahnlicher Form noch bei keiner anderen Institution eingereicht. Ich habe bisher keine erfolglosen Promotionsversuche un- ternommen. D¨usseldorf,den . ... ... ... (Aaron Weimann) Statement of authorship I hereby certify that this dissertation is the result of my own work. No other person's work has been used without due acknowledgement. This dissertation has not been submitted in the same or similar form to other institutions. I have not previously failed a doctoral examination procedure. Summary Bacteria live in almost any imaginable environment, from the most extreme envi- ronments (e.g. in hydrothermal vents) to the bovine and human gastrointestinal tract. By adapting to such diverse environments, they have developed a large arsenal of enzymes involved in a wide variety of biochemical reactions. While some such enzymes support our digestion or can be used for the optimization of biotechnological processes, others may be harmful { e.g. mediating the roles of bacteria in human diseases.
    [Show full text]
  • Dolosigranulum Pigrum Modulates Immunity Against SARS-Cov-2 in Respiratory Epithelial Cells
    pathogens Communication Dolosigranulum pigrum Modulates Immunity against SARS-CoV-2 in Respiratory Epithelial Cells Md. Aminul Islam 1,2 , Leonardo Albarracin 1,3 , Vyacheslav Melnikov 4 , Bruno G. N. Andrade 5 , Rafael R. C. Cuadrat 6,7 , Haruki Kitazawa 1,8,* and Julio Villena 1,3,* 1 Food and Feed Immunology Group, Laboratory of Animal Food Function, Graduate School of Agricultural Science, Tohoku University, Sendai 981-8555, Japan; [email protected] (M.A.I.); [email protected] (L.A.) 2 Department of Medicine, Faculty of Veterinary Science, Bangladesh Agricultural University, Mymensingh 2202, Bangladesh 3 Laboratory of Immunobiotechnology, Reference Centre for Lactobacilli (CERELA-CONICET), Tucumán 4000, Argentina 4 Gabrichevsky Research Institute for Epidemiology and Microbiology, 125212 Moscow, Russia; [email protected] 5 AdaptCentre, Munster Technological University (MTU), T12 P928 Cork, Ireland; [email protected] 6 Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin Institute for Medical Systems Biology (BIMSB), 13125 Berlin, Germany; [email protected] 7 Department of Molecular Epidemiology, German Institute of Human Nutrition Potsdam-Rehbrücke, 14558 Nuthetal, Germany 8 Livestock Immunology Unit, International Education and Research Center for Food and Agricultural Immunology (CFAI), Graduate School of Agricultural Science, Tohoku University, Sendai 981-8555, Japan * Correspondence: [email protected] (H.K.); [email protected] (J.V.) Citation: Islam, M..A.; Albarracin, L.; Melnikov, V.; Andrade, B.G.N.; Abstract: In a previous work, we demonstrated that nasally administered Dolosigranulum pigrum Cuadrat, R.R.C.; Kitazawa, H.; 040417 beneficially modulated the respiratory innate immune response triggered by the activation Villena, J.
    [Show full text]
  • Downloaded from NCBI (NZ AGXA00000000.1) And
    bioRxiv preprint doi: https://doi.org/10.1101/678698; this version posted March 4, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. 1 Dolosigranulum pigrum cooperation and competition in human nasal microbiota 2 Silvio D. Brugger1, 2, 3, 10*, Sara M. Eslami2,10, Melinda M. Pettigrew4,10, Isabel F. 3 Escapa2,3,5, Matthew T. Henke6, Yong Kong7 and Katherine P. Lemon2,5,8,9* 4 1Department of Infectious Diseases and Hospital Epidemiology, University Hospital 5 Zurich, University of Zurich, Zurich, Switzerland, CH-8006 6 2The Forsyth Institute (Microbiology), Cambridge, MA, USA, 02142 7 3Department of Oral Medicine, Infection and Immunity, Harvard School of Dental 8 Medicine, Boston, MA, USA, 02115 9 4Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New 10 Haven, 11 CT, USA, 06510 12 5Alkek Center for Metagenomics & Microbiome Research, Department of Molecular 13 Virology & Microbiology, Baylor College of Medicine, Houston, Texas, USA 77030 14 6Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical 15 School, Boston, MA, USA, 02115 16 7Department of Molecular Biophysics and Biochemistry and W.M. Keck Foundation 17 Biotechnology Resource Laboratory, Yale University, New Haven, CT, USA, 06519 18 8Division of Infectious Diseases, Boston Children’s Hospital, Harvard Medical School, 19 Boston, MA, USA, 02115 1 bioRxiv preprint doi: https://doi.org/10.1101/678698; this version posted March 4, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.
    [Show full text]
  • Microbial and Clinical Factors Are Related to Recurrence of Symptoms After Childhood Lower Respiratory Tract Infection
    Early View Original article Microbial and clinical factors are related to recurrence of symptoms after childhood lower respiratory tract infection Emma M. de Koff, Wing Ho Man, Marlies A. van Houten, Arine M. Vlieger, Mei Ling J.N. Chu, Elisabeth A.M. Sanders, Debby Bogaert Please cite this article as: de Koff EM, Man WH, van Houten MA, et al. Microbial and clinical factors are related to recurrence of symptoms after childhood lower respiratory tract infection. ERJ Open Res 2021; in press (https://doi.org/10.1183/23120541.00939-2020). This manuscript has recently been accepted for publication in the ERJ Open Research. It is published here in its accepted form prior to copyediting and typesetting by our production team. After these production processes are complete and the authors have approved the resulting proofs, the article will move to the latest issue of the ERJOR online. Copyright ©The authors 2021. This version is distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. For commercial reproduction rights and permissions contact [email protected] Microbial and clinical factors are related to recurrence of symptoms after childhood lower respiratory tract infection Emma M. de Koff1,2, Wing Ho Man1,3, Marlies A. van Houten1,4, Arine M. Vlieger5, Mei Ling J.N. Chu2, Elisabeth A.M. Sanders2,6, Debby Bogaert2,7 1. Spaarne Academy, Spaarne Gasthuis, Hoofddorp and Haarlem, Netherlands 2. Department of Paediatric Immunology and Infectious Diseases, Wilhelmina Children’s Hospital and University Medical Centre Utrecht, Utrecht, Netherlands 3. Department of Paediatrics, Willem-Alexander Children’s Hospital and Leiden University Medical Centre, Leiden, Netherlands 4.
    [Show full text]
  • Optimizing Identification of Clinically Relevant Gram-Positive Organisms by Use of the Bruker Biotyper Matrix-Assisted Laser
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Digital Commons@Becker Washington University School of Medicine Digital Commons@Becker Open Access Publications 2013 Optimizing identification of clinically relevant gram-positive organisms by use of the bruker biotyper matrix-assisted laser desorption ionization-time of flight mass spectrometry system Erin McElvania TeKippe Washington University School of Medicine in St. Louis Sunni Shuey St. Louis Children's Hospital David W. Winkler St. Louis Children's Hospital Meghan A. Butler St. Louis Children's Hospital Carey-Ann Burnham Washington University School of Medicine in St. Louis Follow this and additional works at: http://digitalcommons.wustl.edu/open_access_pubs Recommended Citation McElvania TeKippe, Erin; Shuey, Sunni; Winkler, David W.; Butler, Meghan A.; and Burnham, Carey-Ann, ,"Optimizing identification of clinically relevant gram-positive organisms by use of the bruker biotyper matrix-assisted laser desorption ionization-time of flight mass spectrometry system." Journal of Clinical Microbiology.51,5. 1421-1427. (2013). http://digitalcommons.wustl.edu/open_access_pubs/2333 This Open Access Publication is brought to you for free and open access by Digital Commons@Becker. It has been accepted for inclusion in Open Access Publications by an authorized administrator of Digital Commons@Becker. For more information, please contact [email protected]. Optimizing Identification of Clinically Relevant Gram-Positive Organisms by Use of the Bruker Biotyper Matrix-Assisted Laser Desorption Ionization−Time of Flight Mass Spectrometry System Downloaded from Erin McElvania TeKippe, Sunni Shuey, David W. Winkler, Meghan A. Butler and Carey-Ann D. Burnham J. Clin. Microbiol. 2013, 51(5):1421.
    [Show full text]
  • Facklamia Sourekii Sp. Nov., Isolated F Rom 1 Human Sources
    International Journal of Systematic Bacteriology (1999), 49, 635-638 Printed in Great Britain Facklamia sourekii sp. nov., isolated f rom NOTE 1 human sources Matthew D. Collins,' Roger A. Hutson,' Enevold Falsen2 and Berit Sj6den2 Author for correspondence : Matthew D. Collins. Tel : + 44 1 18 935 7226. Fax : + 44 1 18 935 7222. e-mail : [email protected] 1 Department of Food Two strains of a Gram-positive catalase-negative, facultatively anaerobic Science and Technology, coccus originating from human sources were characterized by phenotypic and University of Reading, Whiteknights, molecular taxonomic methods. The strains were found to be identical to each Reading RG6 6AP, other based on 165 rRNA gene sequencing and constitute a new subline within UK the genus Facklamia. The unknown bacterium was readily distinguished from * Culture Collection, Facklamis hominis and Facklamia ignava by biochemicaltests and Department of Clinical electrophoretic analysis of whole-cell proteins. Based on phylogenetic and Bacteriology, University of Goteborg, Sweden phenotypic evidence it is proposed that the unknown bacterium be classified as Facklamia sourekii sp. nov., the type strain of which is CCUG 28783AT. Keywords : Facklamia sourekii, taxonomy, phylogeny, 16s rRNA The Gram-positive catalase-negative cocci constitute a Gram-positive coccus-shaped organisms, which con- phenotypically heterogeneous group of organisms stitute a third species of the genus Facklamia, Fack- which belong to the Clostridium branch of the Gram- lamia sourekii sp. nov. This report adds to the many positive bacteria. This broad group of organisms new taxa and the diversity of Gram-positive catalase- includes many human and animal pathogens (e.g.
    [Show full text]
  • Bacterial Microbiota Analysis Present in the Nose and Pharynx of a Mexican Young Population
    Int.J.Curr.Microbiol.App.Sci (2016) 5(6): 223-235 International Journal of Current Microbiology and Applied Sciences ISSN: 2319-7706 Volume 5 Number 6 (2016) pp. 223-235 Journal homepage: http://www.ijcmas.com Original Research Article http://dx.doi.org/10.20546/ijcmas.2016.506.026 Bacterial Microbiota Analysis Present in the Nose and Pharynx of a Mexican Young Population Ana Karina Rodríguez-Vicente1, Jaime Bustos-Martínez2, Dolores Reyes-Duarte3 and Teresita Sainz-Espuñes4* 1Doctorado en Ciencias Biológicas y de la Salud. Universidad Autónoma Metropolitana-Xochimilco. Mexico City, Mexico 2Departamento de Atención a la Salud. Universidad Autónoma Metropolitana-Xochimilco, Mexico City, Mexico 3Departamento de Procesos y Tecnología. Universidad Autónoma Metropolitana-Cuajimalpa, Mexico City, Mexico 4Departamento de Sistemas Biológicos. Universidad Autónoma Metropolitana-Xochimilco, Mexico City, Mexico *Corresponding author email id: ABSTRACT Culture-independent microbiota is relatively unexplored in Mexican population. The aim of this study was to characterize the microbiota of Mexican young healthy adults by means of K eywo rd s traditional culture and metagenomic analysis in order to provide novel insights and have a better understanding about the healthy baselines from which to detect differences associated Bacterial with diseases. The bacterial microbiota of the nose and pharynx from 75 healthy Microbiota, nonsmoking Mexican young adults was examined by conventional cultures and culture- Nose and independent methods. The hypervariable region (V6-V8) of the16S rRNA gene was PCR Pharynx , amplified from isolated DNA and DGGE analyzed, bands excised were sequenced and metagenomic phylogenetic analys is was done. The study showed that the bacterial microbiota of analysis . the pharynx was richer than that of the nose.
    [Show full text]
  • WO 2015/071474 A2 21 May 2015 (21.05.2015) P O P C T
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date WO 2015/071474 A2 21 May 2015 (21.05.2015) P O P C T (51) International Patent Classification: Krzysztof; Simmeringer Hauptstrasse 45/8, A-1 110 Vi C12N 15/11 (2006.01) enna (AT). FONFARA, Ines; Helmstedter Strasse 144, 38102 Braunschweig (DE). (21) International Application Number: PCT/EP2014/074813 (74) Agent: PILKINGTON, Stephanie Joan; Potter Clarkson LLP, The Belgrave Centre, Talbot Street, Nottingham NG1 (22) International Filing Date: 5GG (GB). 17 November 2014 (17.1 1.2014) (81) Designated States (unless otherwise indicated, for every (25) Filing Language: English kind of national protection available): AE, AG, AL, AM, (26) Publication Language: English AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, (30) Priority Data: DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, 61/905,835 18 November 2013 (18. 11.2013) US HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, (71) Applicant: CRISPR THERAPEUTICS AG [CH/CH]; KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, Aeschenvorstadt 36, CH-4051 Basel (CH). MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, (72) Inventors: CHARPENTIER, Emmanuelle; Boeckler- SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, strasse 18, 38102 Braunschweig (DE).
    [Show full text]
  • The Microbiome of the Middle Meatus in Healthy Adults
    The Microbiome of the Middle Meatus in Healthy Adults Vijay R. Ramakrishnan1*, Leah M. Feazel2, Sarah A. Gitomer1, Diana Ir2, Charles E. Robertson4, Daniel N. Frank2,3 1 Department of Otolaryngology-Head and Neck Surgery, University of Colorado, Aurora, Colorado, United States of America, 2 Division of Infectious Diseases, University of Colorado, Aurora, Colorado, United States of America, 3 Microbiome Research Consortium, University of Colorado, Aurora, Colorado, United States of America, 4 Department of Molecular, Cellular, and Developmental Biology, University of Colorado, Boulder, Colorado, United States of America Abstract Rhinitis and rhinosinusitis are multifactorial disease processes in which bacteria may play a role either in infection or stimulation of the inflammatory process. Rhinosinusitis has been historically studied with culture-based techniques, which have implicated several common pathogens in disease states. More recently, the NIH Human Microbiome Project has examined the microbiome at a number of accessible body sites, and demonstrated differences among healthy and diseased patients. Recent DNA-based sinus studies have suggested that healthy sinuses are not sterile, as was previously believed, but the normal sinonasal microbiome has yet to be thoroughly examined. Middle meatus swab specimens were collected from 28 consecutive patients presenting with no signs or symptoms of rhinosinusitis. Bacterial colonization was assessed in these specimens using quantitative PCR and 16S rRNA pyrosequencing. All subjects were positive for bacterial colonization of the middle meatus. Staphylococcus aureus, Staphylococcus epidermidis and Propionibacterium acnes were the most prevalent and abundant microorganisms detected. Rich and diverse bacterial assemblages are present in the sinonasal cavity in the normal state, including opportunistic pathogens typically found in the nasopharynx.
    [Show full text]
  • High Frequency and Diversity of Antimicrobial Activities Produced by Nasal Staphylococcus Strains Against Bacterial Competitors
    RESEARCH ARTICLE High Frequency and Diversity of Antimicrobial Activities Produced by Nasal Staphylococcus Strains against Bacterial Competitors Daniela Janek1,2¤, Alexander Zipperer1,2, Andreas Kulik3,2, Bernhard Krismer1,2*, Andreas Peschel1,2 a11111 1 Interfaculty Institute of Microbiology and Infection Medicine, Infection Biology, Eberhard-Karls-University Tübingen, Tübingen, Germany, 2 German Center for Infection Research, Partner site Tübingen, Tübingen, Germany, 3 Interfaculty Institute of Microbiology and Infection Medicine, Microbiology/Biotechnology, Eberhard-Karls-University Tübingen, Tübingen, Germany ¤ Current address: Boehringer Ingelheim, Biberach, Germany * [email protected] OPEN ACCESS Citation: Janek D, Zipperer A, Kulik A, Krismer B, Abstract Peschel A (2016) High Frequency and Diversity of Antimicrobial Activities Produced by Nasal The human nasal microbiota is highly variable and dynamic often enclosing major patho- Staphylococcus Strains against Bacterial gens such as Staphylococcus aureus. The potential roles of bacteriocins or other mecha- Competitors. PLoS Pathog 12(8): e1005812. nisms allowing certain bacterial clones to prevail in this nutrient-poor habitat have hardly doi:10.1371/journal.ppat.1005812 been studied. Of 89 nasal Staphylococcus isolates, unexpectedly, the vast majority (84%) Editor: Gongyi Zhang, National Jewish Health, was found to produce antimicrobial substances in particular under habitat-specific stress UNITED STATES conditions, such as iron limitation or exposure to hydrogen peroxide. Activity spectra were Received: March 3, 2016 generally narrow but highly variable with activities against certain nasal members of the Accepted: July 15, 2016 Actinobacteria, Proteobacteria, Firmicutes, or several groups of bacteria. Staphylococcus Published: August 4, 2016 species and many other Firmicutes were insusceptible to most of the compounds. A repre- sentative bacteriocin was identified as a nukacin-related peptide whose inactivation Copyright: © 2016 Janek et al.
    [Show full text]